Marketing and Safety Concerns for Compounded GLP-1 Receptor Agonists

This Viewpoint discusses supply and demand for glucagon-like peptide 1 (GLP-1) receptor agonists and concerns with using compounded drugs to fill this demand.

from JAMA Health Forum New Online https://ift.tt/GK2i9j3